Pelago Bioscience is a CRO providing in situ target engagement studies to accelerate preclinical and clinical drug discovery and development. Our patented Cellular Thermal Shift Assay (CETSA®), unlike other solutions on the market today, allows the assessment and quantification of target engagement under physiological conditions – without the need to modify the compound or protein. The examples of CETSA® utility range from target identification and validation studies, MoA studies, lead generation, and lead optimization efforts, and drug candidate profiling to translational science and rational biomarker discovery. This makes CETSA® a keystone of decision-making throughout the drug discovery pipeline. Any time you need it.
We produce cutting edge congresses and summits for the Life Sciences Industry, bringing together industry leaders and solution providers at a senior level, creating the opportunity to partner, network and knowledge share.